dgppn kongress

272
PROGRAMME OVERVIEW
BY TOPICS
OVERVIEW BY TOPICS
TOPIC 1:
Neurocognitive disorders, organic
mental disorders, dementia, F0
HS-14 | Main Symposium 287
Prevention of dementia
ST-16 | State-of-the-Art-Symposium 287
Dementia
TOPIC 3:
Psychotic disorders, F2
B-08 | Special Session 284
Breakthroughs in Psychiatry: Are there
innovations in the pharmacotherapy of
Schizophrenia foreseeable? State of the
art and new directions
S-075 | Symposium 286
Cognitive behaviour therapy for psychosis:
Evidence based efficacy and novel
approaches
PL-02 | Plenary Session 286
Pathogenic mechanisms in early psychosis:
implications for diagnosis and
treatment
ST-12 | State-of-the-Art-Symposium 286
Psychotic Disorders
S-104 | Symposium 288
The role of oligodendrocytes in symptom
dimensions of schizophrenia
S-168 | Symposium 290
Schizophrenia (Imaging) Genetics: From
bench to bedside – The next steps
ST-15 | State-of-the-Art-Symposium 287
Recent developments in the treatment
of unipolar depressions
TOPIC 5:
Neurotic, stress-related and somatoform
disorders, F4
B-22 | Special Session 282
Trauma and migration – Refugees and
asylum seekers in mental health care
L-05 | Lecture 287
Let‘s not make a bad thing worse
PL-04 | Plenary Session 291
Neurobiological and psychiatric consequences
of child maltreatment
TOPIC 8:
Disorders closely related to childhood
and adolescence, F7-9
PL-03 | Plenary Session 289
Parent-infant synchrony and the crossgeneration
transmission of psychopathology
and resilience
TOPIC 9:
Comorbidity of mental and somatic
disorders, psychosomatics
L-03 | Lecture 284
Mental and physical multimorbidity
TOPIC 4:
Affective disorders, F3
PC-01 | Pro-Con-Debate 283
Effects of selective serotonin re-uptake
inhibition on mortality, morbidity
and mood in depressed heart failure
patients